Handa Pharmaceuticals, Inc. (TPEX: 6620)

Handa Pharmaceuticals Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	835.32	667.05	365.91	263.31	280.12	410.48
Short-Term Investments	1,693	1,650	-	19.96	34.98	225.67
Cash & Short-Term Investments	2,528	2,317	365.91	283.27	315.09	636.16
Cash Growth	325.82%	533.18%	29.17%	-10.10%	-50.47%	15.66%
Accounts Receivable	216.06	376.37	153.48	7.79	21.64	20.5
Other Receivables	18.55	16.2	8.02	7.62	6.08	4.83
Receivables	234.6	392.57	161.51	15.4	27.72	25.33
Prepaid Expenses	2.44	1.81	2.42	2.33	22.38	44.34
Other Current Assets	2.67	3.64	63.02	13.34	43.7	2.51
Total Current Assets	2,768	2,715	592.86	314.33	408.9	708.33
Property, Plant & Equipment	44.27	21.03	43.04	41.83	44.78	54.49
Long-Term Investments	65.74	61.86	-	-	-	-
Goodwill	34.95	34.95	34.95	34.95	34.95	34.95
Other Intangible Assets	0.45	0.59	1.07	1.31	-	4.5
Long-Term Deferred Tax Assets	230.06	202.85	117.23	105.18	91.08	53.08
Other Long-Term Assets	2.38	1.04	1.43	0.93	2.73	21.11
Total Assets	3,146	3,037	790.56	498.53	582.44	876.46
Accounts Payable	4.47	13.97	6.22	1.08	9.36	14.09
Accrued Expenses	32.48	52.18	18.53	14.61	17.59	16.97
Current Portion of Leases	5.74	5.57	10.14	6.2	7.82	8.13
Current Income Taxes Payable	92.83	124.76	1.34	0.01	0.01	0.04
Other Current Liabilities	20.48	13.01	9.13	7.84	3.12	3.17
Total Current Liabilities	155.99	209.49	45.35	29.73	37.9	42.4
Long-Term Leases	31.15	7.67	19.46	5.7	5.54	12.17
Long-Term Unearned Revenue	39.43	39.43	-	-	-	-
Long-Term Deferred Tax Liabilities	15.38	23.81	4.63	-	-	0.29
Other Long-Term Liabilities	2.76	0.49	-	-	-	-
Total Liabilities	244.7	280.88	69.44	35.43	43.44	54.86
Common Stock	1,411	1,411	1,302	1,221	1,157	1,156
Additional Paid-In Capital	1,252	1,253	579.02	338.41	231.74	229.73
Retained Earnings	293.58	215.2	-1,089	-1,049	-801	-518.9
Comprensive Income & Other	-55.64	-123.18	-70.76	-47.93	-48.76	-44.88
Shareholders' Equity	2,901	2,756	721.12	463.1	539	821.6
Total Liabilities & Equity	3,146	3,037	790.56	498.53	582.44	876.46
Total Debt	36.89	13.24	29.59	11.89	13.36	20.3
Net Cash (Debt)	2,491	2,304	336.32	271.38	301.73	615.86
Net Cash Growth	331.44%	584.95%	23.93%	-10.06%	-51.01%	12.48%
Net Cash Per Share	17.80	17.10	2.68	2.31	2.61	5.61
Filing Date Shares Outstanding	141.09	141.09	130.16	122.13	115.7	115.57
Total Common Shares Outstanding	141.09	141.09	130.16	122.13	115.7	115.57
Working Capital	2,612	2,505	547.5	284.61	371	665.93
Book Value Per Share	20.56	19.54	5.54	3.79	4.66	7.11
Tangible Book Value	2,866	2,721	685.11	426.85	504.05	782.16
Tangible Book Value Per Share	20.31	19.28	5.26	3.50	4.36	6.77
Machinery	58.73	55.98	66.98	76.07	70.51	65.67
Leasehold Improvements	12.64	12.64	15.54	15.49	15.79	15.76

Source: S&P Capital IQ. Standard template. Financial Sources.